Search | IOVS | ARVO Journals

Showing 1 – 20 of 226

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Ocular findings in patients undergoing cancer treatment

Jacqueline Coblentz; Christina Mastromonaco; Sabrina Bergeron; Georges Nassrallah; Ana Beatriz Dias; Anelise Savaris Dias; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):45. doi:

ARVO Annual Meeting Abstract June 2021

Optical biopsies of peri-ocular skin cancers: how OCT imaging can heighten accessibility to specialized healthcare by telemedicine.

Sabrina Bergeron; Christina Mastromonaco; Jacqueline Coblentz; Mohamed Abdouh; Hiroaki Ito; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2459. doi:

ARVO Annual Meeting Abstract June 2021

Unintended Placement of Intraocular Lens Haptics in the Sulcus and Association with Posterior Capsular Opacification

Raphaelle Denis; Georges Nassrallah; Ana Beatriz Dias; Hiroaki Ito; Christina Mastromonaco; Nabil Saheb; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2069. doi:

ARVO Annual Meeting Abstract June 2021

Potential mechanism of action of Mifepristone as antitumor treatment in Uveal melanoma

Prisca Raquel Bustamante; Alexander Laskaris; Alicia Alejandra Goyeneche; Miguel N Burnier; Carlos Telleria; Julia Valdemarin Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2871. doi:

ARVO Annual Meeting Abstract June 2021

Deleterious genotoxic, metabolic, and oxidative stress effects of sunlight exposure on keratinocytes and fibroblasts

Alicia Alejandra Goyeneche; Mohamed Abdouh; Emma Youhnovska; Paulina Garcia de Alba Graue; Christina Mastromonaco; Myriam Caruso McDonald; Julia Valdemarin Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2848. doi:

ARVO Annual Meeting Abstract June 2021

Histopathological and immunohistochemical study of metastatic orbital tumors

Hiroaki Ito; Georges Nassrallah; Sabrina Bergeron; Jacqueline Coblentz; Alicia Alejandra Goyeneche; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2846. doi:

ARVO Annual Meeting Abstract June 2021

Objective Analysis of Capsulorhexis factors and Posterior Capsular Opacification in 246 Post-Mortem Eyes

Georges Nassrallah; Christina Mastromonaco; Raphaelle Denis; Ana Beatriz Dias; Nabil Saheb; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2793. doi:

ARVO Annual Meeting Abstract June 2021

Diagnosis and histopathological evaluation of soft drusen in patients that underwent evisceration and enucleation

Anelise Savaris Dias; Hiroaki Ito; Sabrina Bergeron; Jacqueline Coblentz; Alicia Alejandra Goyeneche; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2723. doi:

ARVO Annual Meeting Abstract June 2021

Drusen Quantification of Eye Bank Eyes Implanted with or without Blue-Light Filtering IOLs: a Histopathological Study

Christina Mastromonaco; Sabrina Bergeron; Jacqueline Coblentz; Mohamed Abdouh; Julia Valdemarin Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2719. doi:

ARVO Annual Meeting Abstract June 2021

Effects of Spectrum of Wavelengths of Blue-Light on Retinal Pigment Epithelial Cells

Mohamed Abdouh; Alicia Alejandra Goyeneche; Emma Youhnovska; Raphaelle Denis; Paulina Garcia de Alba Graue; Julia Valdemarin Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):266. doi:

ARVO Annual Meeting Abstract June 2020

Histopathological variability and concomitant lesions in pterygium; what we learned from a large case series.

Sabrina Bergeron; Christina Mastromonaco; Juliana Portela Passos; Sabrina Parent; Gerardo Discepola; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2799. doi:

ARVO Annual Meeting Abstract June 2020

Driver Gene SOX4 in Retinoblastoma

Camille Zeitouni; Eloise Caterina Passarella; Ilana Singer; Sabrina Bergeron; Jacqueline Coblentz; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2821. doi:

ARVO Annual Meeting Abstract June 2020

Tenascin-C expression in retinoblastoma: A novel therapeutic target?

Luis García Onrubia; jessica araujo sousa; Simon Trottier; Sabrina Bergeron; María Antonia Saornil; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2823. doi:

ARVO Annual Meeting Abstract June 2020

The expression of ALK, RET, ROS1, c-MET, EGFR and IGF-R1 in uveal melanoma and its association to clinicopathological characteristics and prognosis.

Rita Pinto Proença; Cristina Fonseca; Alicia Alejandra Goyeneche; Hiroaki Ito; Ana Dias; Carlos Marques-Neves; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2833. doi:

ARVO Annual Meeting Abstract June 2020

Horizontal transfer of malignant traits via blood-derived extracellular vesicles of uveal melanoma patients

Mohamed Abdouh; Thupten Tsering; Julia Valdemarin Burnier; Paulina Garcia de Alba Graue; Goffredo Orazio Arena; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2835. doi:

ARVO Annual Meeting Abstract June 2020

Expression of BAP1 mutation in primary tumors and metastasis in an animal model of uveal melanoma

Clara Castro; Jacqueline Coblentz; Sabrina Bergeron; Christina Mastromonaco; Tadhg Ferrier; Julia Valdemarin Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2837. doi:

ARVO Annual Meeting Abstract June 2020

PHENOTYPICAL CHARACTERIZATION OF INDUCED CD33+ AND CD11b+ MYELOID CELLS FROM PERIPHERAL BLOOD AFTER CO-CULTURE WITH A METASTATIC UVEAL MELANOMA CELL LINE

Cristina Fonseca; Rita Pinto Proença; Ekaterina Yurchenko; Alicia Alejandra Goyeneche; Paulina Garcia de Alba Graue; Rui Proença; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2838. doi:

ARVO Annual Meeting Abstract June 2020

Cancer stem cells markers and prognosis in uveal melanoma

Isabela Vianello Valle; Sabrina Bergeron; Christina Mastromonaco; Jacqueline Coblentz; Julia Valdemarin Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2840. doi:

ARVO Annual Meeting Abstract June 2020

Characterization of Extracellular Vesicles purified from plasma, aqueous humor and vitreous from patients with uveal melanoma

CARMEN LUZ PESSUTI; Deise Fialho Costa; Kleber Silva Ribeiro; Thupten Tsering; Heloisa Nascimento; Alessandra G. Commodaro; Ana Trocoli Torrecilhas; Rubens Belfort; Julia Valdemarin Burnier; Rubens Belfort Jr.; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2841. doi:

ARVO Annual Meeting Abstract June 2020

The anti-asthmatic drug MK571 as a potential therapeutic agent for Uveal Melanoma

Paulina Garcia de Alba Graue; Alicia Alejandra Goyeneche; Mohamed Abdouh; Tadhg Ferrier; Ana Dias; Alexander Laskaris; Jacqueline Coblentz; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3614. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Ocular findings in patients undergoing cancer treatment

Optical biopsies of peri-ocular skin cancers: how OCT imaging can heighten accessibility to specialized healthcare by telemedicine.

Unintended Placement of Intraocular Lens Haptics in the Sulcus and Association with Posterior Capsular Opacification

Potential mechanism of action of Mifepristone as antitumor treatment in Uveal melanoma

Deleterious genotoxic, metabolic, and oxidative stress effects of sunlight exposure on keratinocytes and fibroblasts

Histopathological and immunohistochemical study of metastatic orbital tumors

Objective Analysis of Capsulorhexis factors and Posterior Capsular Opacification in 246 Post-Mortem Eyes

Diagnosis and histopathological evaluation of soft drusen in patients that underwent evisceration and enucleation

Drusen Quantification of Eye Bank Eyes Implanted with or without Blue-Light Filtering IOLs: a Histopathological Study

Effects of Spectrum of Wavelengths of Blue-Light on Retinal Pigment Epithelial Cells

Histopathological variability and concomitant lesions in pterygium; what we learned from a large case series.

Driver Gene SOX4 in Retinoblastoma

Tenascin-C expression in retinoblastoma: A novel therapeutic target?

The expression of ALK, RET, ROS1, c-MET, EGFR and IGF-R1 in uveal melanoma and its association to clinicopathological characteristics and prognosis.

Horizontal transfer of malignant traits via blood-derived extracellular vesicles of uveal melanoma patients

Expression of BAP1 mutation in primary tumors and metastasis in an animal model of uveal melanoma

PHENOTYPICAL CHARACTERIZATION OF INDUCED CD33+ AND CD11b+ MYELOID CELLS FROM PERIPHERAL BLOOD AFTER CO-CULTURE WITH A METASTATIC UVEAL MELANOMA CELL LINE

Cancer stem cells markers and prognosis in uveal melanoma

Characterization of Extracellular Vesicles purified from plasma, aqueous humor and vitreous from patients with uveal melanoma

The anti-asthmatic drug MK571 as a potential therapeutic agent for Uveal Melanoma

To View More...

You must be signed into an individual account to use this feature.